查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1986292

全球醫療器材市場：市場規模、佔有率和趨勢分析（按應用、最終用途和地區分類），細分市場預測（2026-2033 年）

Therapy Devices Market Size, Share & Trends Analysis Report By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

醫療器材市場概述

2025年全球醫療器材市場規模估計為272.3億美元，預計2033年將達到470.6億美元。

預計從 2026 年到 2033 年，該市場將以 6.09% 的複合年成長率成長。這一成長歸因於疼痛和肌肉骨骼疾病負擔的加重，以及先進的神經系統治療和心理健康解決方案的日益普及。

例如，根據英國抗關節炎組織（Versus Arthritis Organization）發布的報告《2024年肌肉骨骼健康狀況》，英國有超過1000萬人患有關節炎。此外，英國每年約有2.7萬名成年人被新診斷出患有類風濕性關節炎。慢性呼吸系統疾病的增加和人口老化也推動了市場成長。此外，政府和私人機構所推行的居家自我管理療法和支持措施也進一步促進了市場成長。

慢性疼痛和肌肉骨骼疾病的日益普遍是推動市場發展的重要因素。盛行率的上升正在加速人們對使用醫療器材的非藥物療法的需求。關節炎、背痛、運動傷害、術後疼痛和與老齡化相關的運動功能障礙等疾病需要重複、局部和長期的治療性介入，而這些干預措施透過治療器械而非間歇性藥物治療效果更佳。這推動了電刺激（經皮神經電刺激，TENS；神經肌肉電刺激，NMES）、超音波療法、冷療、熱療和雷射療法等設備在臨床和居家照護中的應用。根據Hinge Health的年度報告《肌肉骨骼（MSK）護理狀況報告》，美國約有40%的成年人患有肌肉骨骼疾病。

此外，復健和物理治療領域的技術創新是市場成長的關鍵驅動力。先進的治療設備如今整合了機器人技術、運動輔助系統和感測器系統，以支持中風、整形外科損傷、神經系統疾病以及與老齡化相關的運動功能衰退的復健。機器人輔助步態訓練器、外骨骼和自動化治療平台能夠實現重複性、高強度和針對特定動作的康復，而這些僅靠手法治療難以實現。這些技術能夠改善功能恢復效果，減輕治療師的疲勞，並提高治療的一致性，從而加速其在醫院、復健中心和專科診所的普及應用。例如，2025年1月，印度理工學院坎普爾分校推出了一款基於腦機介面（BCI）的機器人手部外骨骼，用於中風康復，它透過封閉回路型控制整合腦波訊號和治療性動作。

此外，慢性阻塞性肺病（COPD）是進行性呼吸系統疾病，影響著約11%的25歲及以上成年人。預計到2050年，全球COPD患者人數將成長23.3%，達到約5.92億。慢性呼吸系統疾病盛行率的上升是市場成長的強勁驅動力。此外，人們對COPD患者呼吸系統合併症（尤其是阻塞型睡眠呼吸中止症症（OSA））的認知不斷提高，有助於提高診斷率並擴大治療需求，從而支持市場的持續成長。

政府和私部門正透過增加設備治療服務的可近性、增加資金投入和提升醫療機構的準備水平，加速推廣治療設備的普及應用。治療設備正日益成為公共衛生計畫（包括慢性病管理、殘疾復健、呼吸系統照護和心理健康計畫）的標準照護工具。政府主導的復健中心、呼吸照護單位和社區醫療基礎設施投資，持續推動了對呼吸治療設備、復健系統、神經治療設備和疼痛管理設備的需求。例如，在美國，疾病管制與預防中心（CDC）已將睡眠呼吸中止症納入其關於睡眠衛生和慢性病管理的公共衛生訊息中。同樣，在英國，國家醫療服務體系（NHS）也在積極宣傳睡眠健康意識提升，並鼓勵人們接受睡眠呼吸中止症的檢測。

目錄

第1章：分析方法和範圍

第2章：治療器材市場：執行摘要

  • 市場展望
  • 細分市場預測
  • 競爭考察

第3章：治療器材市場：影響因素、趨勢與範圍

  • 市場歷史及展望
    • 母市場展望
    • 相關市場展望
  • 市場動態
  • EMS生態系概覽：依地區分類
  • 對OEM和EMS製造模式的評估
  • 外包滲透率：依治療設備細分市場分類
  • 治療設備設計與技術的演變
  • 價值鏈分析（PCBA、系統整合、測試、最終組裝）
  • 全球醫療器材市場：分析工具
    • 產業分析：波特五力分析
    • PESTLE分析

第4章 治療設備市場：依應用領域分類（以收益為準：百萬美元，2021-2033 年）

  • 市場佔有率分析：按應用領域分類（2025 年和 2033 年）
  • 全球醫療器材市場：按應用領域分類的展望
  • 市場規模、預測與趨勢分析（2021-2033）

第5章 治療設備市場：依最終用途分類（以收益為準：百萬美元，2021-2033 年）

  • 定義和範圍
  • 市場佔有率分析：依最終用途分類（2025 年和 2033 年）
  • 全球醫療器材市場：按最終用途分類的展望
  • 市場規模、預測與趨勢分析（2021-2033）

第6章 治療設備市場：區域細分（以收益為準：百萬美元，2021-2033 年）

  • 市場佔有率分析：按地區分類（2025 年和 2033 年）
  • 市場概覽：按地區
  • 全球市場概覽：按地區分類
  • 治療器材市場佔有率：按地區分類（2025 年和 2033 年）
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第7章 競爭情勢

  • 疼痛管理裝置
    • 參與公司概況
    • 研發重點領域與銷售管道分析
    • 財務業績
    • 產品基準測試
    • SWOT分析
    • 策略藍圖
  • 企業市場占有率分析（2025 年）
    • 疼痛管理設備
    • 復健和物理治療設備
    • 呼吸治療裝置
    • 心理健康與神經治療設備
    • 其他治療設備
  • 公司簡介：疼痛管理
    • PAJUNK
    • OMRON Healthcare, Inc.
    • Zynex Medical
    • Litemed
    • DJO Global
    • Boston Scientific Corporation
    • SPR
    • Medtronic
    • Nalu Medical, Inc.
    • Abbott
    • Atricure, Inc.
    • ThermaCare
    • Avanos Medical, Inc
    • ICU Medical, Inc.
    • Dynatronics Corporation
    • RS Medical
    • Bioventus
    • BioElectronics Corporation
    • ProMedTek Inc.
    • InfuSystem
    • Gladiator Therapeutics
    • PAIN MANAGEMENT TECHNOLOGIES, INC.
    • PainPod
    • BioWave Corporation
    • DIS&L;
    • TrueRelief, LLC
    • MAI Medical
    • Compex
    • Pain Care Labs
    • PowerCure Europe
  • 公司概況、研發重點領域與銷售管道分析
    • PAJUNK
    • OMRON Healthcare, Inc.
    • Zynex Medical
    • Litemed
    • DJO Global
    • Boston Scientific Corporation
    • SPR
    • Medtronic
    • Nalu Medical, Inc.
    • Abbott
    • Atricure, Inc.
    • ThermaCare
    • Avanos Medical, Inc
    • ICU Medical, Inc.
    • Dynatronics Corporation
    • RS Medical
    • Bioventus
    • BioElectronics Corporation
    • ProMedTek Inc.
    • InfuSystem
    • Gladiator Therapeutics
    • PAIN MANAGEMENT TECHNOLOGIES, INC.
    • PainPod
    • BioWave Corporation
    • DIS&L;
    • TrueRelief, LLC
    • MAI Medical
    • Compex
    • Pain Care Labs
    • PowerCure Europe
  • 公司簡介：珠江三角洲Delta的緊急醫療服務 (EMS) 提供者
    • Shenzhen WELLD Medical Electronics Co., Ltd.
    • Longest Medical
    • Shenzhen Roundwhale Technology Co., Ltd
    • Shenzhen Xinmaikang Technology Co., Ltd.
    • Huizhou Huan Dong Industrial Co., Ltd.
    • Yunblaze Technology China
    • Hong Qiangxing（Shenzhen）Electronics Limited
    • Shenzhen Jrw Technology Co., Ltd.
    • Quanding Medical
    • Shenzhen Xinkang Health Technology Co., Ltd.
Product Code: GVR-4-68040-861-2

Therapy Devices Market Summary

The global therapy devices market size was estimated at USD 27.23 billion in 2025 and is projected to reach USD 47.06 billion by 2033, growing at a CAGR of 6.09% from 2026 to 2033. The growth is attributed to the growing burden of pain & musculoskeletal disorders and rising adoption of advanced neurotherapy and mental health solutions.

For instance, according to the report The State of Musculoskeletal Health 2024 published by the Versus Arthritis Organization, more than 10 million people in the UK have arthritis. In addition, around 27,000 adults are newly diagnosed with rheumatoid arthritis each year in the UK. The rise in chronic respiratory diseases and growing geriatric population further contribute to market growth. Moreover, growing shift towards home-based and self-administered therapy and supportive initiatives by government and private organizations drive market growth further.

The increasing prevalence of chronic pain and musculoskeletal disorders is a significant driver for the market. This increasing prevalence is accelerating the demand for device-based, non-pharmacological therapies. Conditions such as arthritis, lower back pain, sports injuries, post-operative pain, and age-related mobility impairment require repetitive, localized, and long-term therapeutic intervention, optimally delivered through therapy devices rather than episodic drug treatment. This drives the adoption of electrical stimulation (TENS, NMES), ultrasound therapy, cryotherapy, thermotherapy, and laser therapy devices across clinical and home care settings. According to Hinge Health's annual State of Musculoskeletal (MSK) Care Report, approximately 40% of adults in the U.S. are affected by MSK conditions.

Moreover, technological innovation in rehabilitation and physical therapy is a key factor driving market growth. Advanced therapy devices now integrate robotics, motorized assistance, and sensor-based systems to support recovery from stroke, orthopedic injuries, neurological disorders, and age-related mobility decline. Robotic-assisted gait trainers, exoskeletons, and automated therapy platforms enable repetitive, high-intensity, and task-specific rehabilitation that is difficult to achieve through manual therapy alone. These technologies improve functional outcomes, reduce therapist fatigue, and increase therapy consistency, driving adoption across hospitals, rehabilitation centers, and specialty clinics. For instance, in January 2025, IIT Kanpur introduced a Brain-Computer Interface (BCI)-based robotic hand exoskeleton for stroke recovery, integrating brain signals with therapeutic movements via closed-loop control.

In addition, Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory condition that affects approximately 11% of adults aged over 25 years, with global COPD cases projected to grow by 23.3% to reach nearly 592 million by 2050. The rising prevalence of chronic respiratory diseases represents a high-impact driver for market growth. In addition, increasing awareness of respiratory comorbidities particularly obstructive sleep apnea (OSA) among COPD patients is contributing to higher diagnosis rates and expanding treatment demand, thereby supporting sustained market expansion.

Government and private-sector initiatives are accelerating the adoption of therapy devices by expanding access, funding, and institutional readiness for device-based therapeutic care. Public health programs targeting chronic disease management, disability rehabilitation, respiratory care, and mental health increasingly incorporate therapy devices as standard care tools. Government-backed investments in rehabilitation centers, pulmonary care units, and community health infrastructure create sustained demand for respiratory therapy devices, rehabilitation systems, neurotherapy devices, and pain management equipment. For instance, in the U.S., the CDC has included sleep apnea in its broader public health messaging about sleep hygiene and chronic disease management. Similarly, in the UK, the National Health Service (NHS) promotes sleep health awareness and encourages people to seek diagnostic testing for sleep apnea.

Global Therapy Devices Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global therapy devices market report based on application, end use, and region:

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Pain Management
    • Electrical Stimulation (TENS/NMES)
    • Cryo / Thermotherapy
    • Laser therapy
    • Ultrasound Therapy
  • Rehabilitation & Physical Therapy
    • Robotic Rehabilitation Systems
    • Virtual Reality Therapy Systems
    • Exoskeleton Devices
    • Electromechanical Therapy Platforms
  • Mental Health & Neurotherapy
    • Neurostimulation (tDCS, TMS)
    • EEG-based Neurofeedback Devices
  • Respiratory Therapy
    • CPAP / BiPAP
    • Non-Invasive Ventilators/Resuscitators
    • Pulmonary Rehab Devices
    • Nebulizers / Aerosol Systems
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Specialty Clinics
  • Rehabilitation Centers
  • Home-care & Consumer Use
  • Long-term Care Facilities
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Methodology
  • 1.8. Information Procurement
  • 1.9. Market-Specific Research Models
    • 1.9.1. Consensus-based Estimates & Forecasting
  • 1.10. Primary Research Methodology
  • 1.11. List of Secondary Sources
  • 1.12. List of Primary Sources

Chapter 2. Therapy Devices Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. End Use Outlook
  • 2.3. Competitive Insights

Chapter 3. Therapy Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Burden of Pain & Musculoskeletal Disorders and Rising Adoption of Advanced Neurotherapy and Mental Health Solutions
      • 3.2.1.2. Rise In Chronic Respiratory Diseases and Growing Geriatric Population
      • 3.2.1.3. Growing Shift Towards Home-Based and Self-Administered Therapy
      • 3.2.1.4. Supportive Initiatives by Government and Private Organizations
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Product Recalls and Device Failure
      • 3.2.2.2. Complex Regulatory Framework for Therapy Devices
    • 3.2.3. Industry Opportunity Analysis
      • 3.2.3.1. Growing Number of Rehabilitation Centers in Developing Countries
      • 3.2.3.2. Shift Toward Minimally Invasive & Non-Invasive Therapies
      • 3.2.3.3. Integration Of AI, Digital Health, And Smart Therapy Devices
      • 3.2.3.4. Growing Adoption of Personalized and Precision Therapy
  • 3.3. Regional EMS Ecosystem Overview
  • 3.4. OEM vs EMS Manufacturing Model Assessment
  • 3.5. Outsourcing Penetration by Therapy Device Sub-Segment
  • 3.6. Evolution of Therapy Device Design & Technology
  • 3.7. Value Chain Analysis (PCBA, System Integration, Testing, Final Assembly)
  • 3.8. Global Therapy Devices: Market Analysis Tools
    • 3.8.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.8.2. PESTLE Analysis

Chapter 4. Therapy Devices Market Segment Analysis, By Application (Revenue in USD Million, 2021 - 2033)

  • 4.1. Application Market Share Analysis, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Therapy Devices Market By Application Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
    • 4.4.1. Pain Management
      • 4.4.1.1. Pain Management Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.4.1.2. Electrical Stimulation (TENS/NMES)
        • 4.4.1.2.1. Electrical Stimulation (TENS/NMES) Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.4.1.3. Cryo / Thermotherapy
        • 4.4.1.3.1. Cryo / Thermotherapy Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.4.1.4. Laser Therapy
        • 4.4.1.4.1. Laser Therapy Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.4.1.5. Ultrasound Therapy
        • 4.4.1.5.1. Ultrasound Therapy Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 4.4.2. Rehabilitation & Physical Therapy
      • 4.4.2.1. Rehabilitation & Physical Therapy Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.4.2.2. Robotic Rehabilitation Systems
        • 4.4.2.2.1. Robotic Rehabilitation Systems Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.4.2.3. Virtual Reality Therapy Systems
        • 4.4.2.3.1. Virtual Reality Therapy Systems Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.4.2.4. Exoskeleton Devices
        • 4.4.2.4.1. Exoskeleton Devices Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.4.2.5. Electromechanical Therapy Platforms
        • 4.4.2.5.1. Electromechanical Therapy Platforms Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 4.4.3. Mental Health & Neurotherapy
      • 4.4.3.1. Mental Health & Neurotherapy Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.4.3.2. Neurostimulation (tDCS, TMS)
        • 4.4.3.2.1. Neurostimulation (tDCS, TMS) Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.4.3.3. EEG-based Neurofeedback Devices
        • 4.4.3.3.1. EEG-based Neurofeedback Devices Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 4.4.4. Respiratory Therapy
      • 4.4.4.1. Respiratory Therapy Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.4.4.2. CPAP / BiPAP
        • 4.4.4.2.1. CPAP / BiPAP Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.4.4.3. Non-invasive ventilators/Resuscitators
        • 4.4.4.3.1. Non-invasive ventilators/Resuscitators Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.4.4.4. Pulmonary Rehab Devices
        • 4.4.4.4.1. Pulmonary Rehab Devices Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.4.4.5. Nebulizers / Aerosol Systems
        • 4.4.4.5.1. Nebulizers / Aerosol Systems Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Estimates and Forecasts 2021 To 2033 (USD Million)

Chapter 5. Therapy Devices Market Segment Analysis, By End Use (Revenue in USD Million, 2021 - 2033)

  • 5.1. Definition and Scope
  • 5.2. End Use Market Share Analysis, 2025 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Therapy Devices Market By End Use Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
    • 5.5.1. Hospitals & Specialty Clinics
      • 5.5.1.1. Hospitals & Specialty Clinics Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 5.5.2. Rehabilitation Centers
      • 5.5.2.1. Rehabilitation Centers Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 5.5.3. Home-care & Consumer Use
      • 5.5.3.1. Home-care & Consumer Use Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 5.5.4. Long-term Care Facilities
      • 5.5.4.1. Long-term Care Facilities Market Estimates and Forecasts 2021 To 2033 (USD Million)

Chapter 6. Therapy Devices Market Segment Analysis, By Region, (Revenue in USD Million, 2021 - 2033)

  • 6.1. Regional Market Share Analysis, 2025 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Therapy Devices Market Share by Region, 2025 & 2033:
  • 6.5. North America
    • 6.5.1. North America Therapy Devices Market, 2021 - 2033 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. U.S. Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Canada Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Mexico Therapy Devices Market, 2021 To 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. Europe Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.6.2. UK
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. UK Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Germany Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.6.4. Spain
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Spain Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.6.5. France
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. France Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.6.6. Italy
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Italy Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.6.7. Denmark
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Denmark Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Competitive Scenario
      • 6.6.8.3. Regulatory Framework
      • 6.6.8.4. Sweden Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.6.9. Norway
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Competitive Scenario
      • 6.6.9.3. Regulatory Framework
      • 6.6.9.4. Norway Therapy Devices Market, 2021 To 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Competitive Scenario
      • 6.7.1.3. Regulatory Framework
      • 6.7.1.4. Japan Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. China Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. India Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.7.4. South Korea
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. South Korea Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.7.5. Thailand
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Thailand Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.7.6. Australia
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory Framework
      • 6.7.6.4. Australia Therapy Devices Market, 2021 To 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Latin America Therapy Devices Market, 2021 - 2033 (USD Million)
    • 6.8.2. Brazil
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Brazil Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Argentina Therapy Devices Market, 2021 To 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. MEA Therapy Devices Market, 2021 - 2033 (USD Million)
    • 6.9.2. South Africa
      • 6.9.2.1. Key Country Dynamics
      • 6.9.2.2. Competitive Scenario
      • 6.9.2.3. Regulatory Framework
      • 6.9.2.4. South Africa Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.9.3. Saudi Arabia
      • 6.9.3.1. Key Country Dynamics
      • 6.9.3.2. Competitive Scenario
      • 6.9.3.3. Regulatory Framework
      • 6.9.3.4. Saudi Arabia Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.9.4. UAE
      • 6.9.4.1. Key Country Dynamics
      • 6.9.4.2. Competitive Scenario
      • 6.9.4.3. Regulatory Framework
      • 6.9.4.4. UAE Therapy Devices Market, 2021 To 2033 (USD Million)
    • 6.9.5. Kuwait
      • 6.9.5.1. Key Country Dynamics
      • 6.9.5.2. Competitive Scenario
      • 6.9.5.3. Regulatory Framework
      • 6.9.5.4. Kuwait Therapy Devices Market, 2021 To 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Pain Management Devices
    • 7.1.1. Participant's Overview
      • 7.1.1.1. Top 30 Pain Management Devices Participant
      • 7.1.1.2. Brand-Owned, R&D-Driven Companies That Do Not Have In-House Manufacturing and Require EMS Partners
      • 7.1.1.3. EMS Providers in Pearl River Delta
    • 7.1.2. R&D Focus and Sales Channel Analysis
      • 7.1.2.1. Top 30 Pain Management Devices Participant
      • 7.1.2.2. Brand-Owned, R&D-Driven Companies That Do Not Have In-House Manufacturing and Require EMS Partners
      • 7.1.2.3. EMS Providers in Pearl River Delta
    • 7.1.3. Financial Performance
      • 7.1.3.1. Top 30 Pain Management Devices Participant
      • 7.1.3.2. Brand-Owned, R&D-Driven Companies That Do Not Have In-House Manufacturing and Require EMS Partners
      • 7.1.3.3. EMS Providers in Pearl River Delta
    • 7.1.4. Product Benchmarking
      • 7.1.4.1. Top 30 Pain Management Devices Participant
      • 7.1.4.2. Brand-Owned, R&D-Driven Companies That Do Not Have In-House Manufacturing and Require EMS Partners
      • 7.1.4.3. EMS Providers in Pearl River Delta
    • 7.1.5. SWOT Analysis
      • 7.1.5.1. Top 30 Pain Management Devices Participant
      • 7.1.5.2. Brand-Owned, R&D-Driven Companies That Do Not Have In-House Manufacturing and Require EMS Partners
      • 7.1.5.3. EMS Providers in Pearl River Delta
    • 7.1.6. Strategy Mapping
      • 7.1.6.1. Product launch
      • 7.1.6.2. Mergers & acquisition
      • 7.1.6.3. Partnerships & collaboration
      • 7.1.6.4. Expansion
      • 7.1.6.5. Other strategies
  • 7.2. Company Market Share Analysis, 2025
    • 7.2.1. Pain Management Devices
      • 7.2.1.1. Top 30 Pain Management Devices Participant
      • 7.2.1.2. Brand-Owned, R&D-Driven Companies That Do Not Have In-House Manufacturing and Require EMS Partners
      • 7.2.1.3. EMS Providers in Pearl River Delta
    • 7.2.2. Rehabilitation & Physical Therapy Devices
      • 7.2.2.1. Top 30 Rehabilitation & Physical Therapy Devices Participant
      • 7.2.2.2. Brand-Owned, R&D-Driven Companies That Do Not Have In-House Manufacturing and Require EMS Partners
      • 7.2.2.3. EMS Providers in Pearl River Delta
    • 7.2.3. Respiratory Therapy Devices
      • 7.2.3.1. Top 30 Respiratory Therapy Devices Participant
      • 7.2.3.2. Brand-Owned, R&D-Driven Companies That Do Not Have In-House Manufacturing and Require EMS Partners
      • 7.2.3.3. EMS Providers in Pearl River Delta
    • 7.2.4. Mental Health & Neurotherapy Devices
      • 7.2.4.1. Top 30 Mental Health & Neurotherapy Devices Participant
      • 7.2.4.2. Brand-Owned, R&D-Driven Companies That Do Not Have In-House Manufacturing and Require EMS Partners
      • 7.2.4.3. EMS Providers in Pearl River Delta
    • 7.2.5. Other Therapy Devices
      • 7.2.5.1. Top 30 Other Therapy Devices Participant
      • 7.2.5.2. Brand-Owned, R&D-Driven Companies That Do Not Have In-House Manufacturing and Require EMS Partners
      • 7.2.5.3. EMS Providers in Pearl River Delta
  • 7.3. Company Profiles, Pain Management
    • 7.3.1. PAJUNK
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Product Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. OMRON Healthcare, Inc.
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Product Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Zynex Medical
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Product Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Litemed
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Product Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. DJO Global
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Product Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Boston Scientific Corporation
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Product Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. SPR
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Product Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Medtronic
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Product Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Nalu Medical, Inc.
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Product Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. Abbott
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Product Benchmarking
      • 7.3.10.4. Strategic Initiatives
    • 7.3.11. Atricure, Inc.
      • 7.3.11.1. Company Overview
      • 7.3.11.2. Financial Performance
      • 7.3.11.3. Product Benchmarking
      • 7.3.11.4. Strategic Initiatives
    • 7.3.12. ThermaCare
      • 7.3.12.1. Company Overview
      • 7.3.12.2. Financial Performance
      • 7.3.12.3. Product Benchmarking
      • 7.3.12.4. Strategic Initiatives
    • 7.3.13. Avanos Medical, Inc
      • 7.3.13.1. Company Overview
      • 7.3.13.2. Financial Performance
      • 7.3.13.3. Product Benchmarking
      • 7.3.13.4. Strategic Initiatives
    • 7.3.14. ICU Medical, Inc.
      • 7.3.14.1. Company Overview
      • 7.3.14.2. Financial Performance
      • 7.3.14.3. Product Benchmarking
      • 7.3.14.4. Strategic Initiatives
    • 7.3.15. Dynatronics Corporation
      • 7.3.15.1. Company Overview
      • 7.3.15.2. Financial Performance
      • 7.3.15.3. Product Benchmarking
      • 7.3.15.4. Strategic Initiatives
    • 7.3.16. RS Medical
      • 7.3.16.1. Company Overview
      • 7.3.16.2. Financial Performance
      • 7.3.16.3. Product Benchmarking
      • 7.3.16.4. Strategic Initiatives
    • 7.3.17. Bioventus
      • 7.3.17.1. Company Overview
      • 7.3.17.2. Financial Performance
      • 7.3.17.3. Product Benchmarking
      • 7.3.17.4. Strategic Initiatives
    • 7.3.18. BioElectronics Corporation
      • 7.3.18.1. Company Overview
      • 7.3.18.2. Financial Performance
      • 7.3.18.3. Product Benchmarking
      • 7.3.18.4. Strategic Initiatives
    • 7.3.19. ProMedTek Inc.
      • 7.3.19.1. Company Overview
      • 7.3.19.2. Financial Performance
      • 7.3.19.3. Product Benchmarking
      • 7.3.19.4. Strategic Initiatives
    • 7.3.20. InfuSystem
      • 7.3.20.1. Company Overview
      • 7.3.20.2. Financial Performance
      • 7.3.20.3. Product Benchmarking
      • 7.3.20.4. Strategic Initiatives
    • 7.3.21. Gladiator Therapeutics
      • 7.3.21.1. Company Overview
      • 7.3.21.2. Financial Performance
      • 7.3.21.3. Product Benchmarking
      • 7.3.21.4. Strategic Initiatives
    • 7.3.22. PAIN MANAGEMENT TECHNOLOGIES, INC.
      • 7.3.22.1. Company Overview
      • 7.3.22.2. Financial Performance
      • 7.3.22.3. Product Benchmarking
      • 7.3.22.4. Strategic Initiatives
    • 7.3.23. PainPod
      • 7.3.23.1. Company Overview
      • 7.3.23.2. Financial Performance
      • 7.3.23.3. Product Benchmarking
      • 7.3.23.4. Strategic Initiatives
    • 7.3.24. BioWave Corporation
      • 7.3.24.1. Company Overview
      • 7.3.24.2. Financial Performance
      • 7.3.24.3. Product Benchmarking
      • 7.3.24.4. Strategic Initiatives
    • 7.3.25. DIS&L
      • 7.3.25.1. Company Overview
      • 7.3.25.2. Financial Performance
      • 7.3.25.3. Product Benchmarking
      • 7.3.25.4. Strategic Initiatives
    • 7.3.26. TrueRelief, LLC
      • 7.3.26.1. Company Overview
      • 7.3.26.2. Financial Performance
      • 7.3.26.3. Product Benchmarking
      • 7.3.26.4. Strategic Initiatives
    • 7.3.27. MAI Medical
      • 7.3.27.1. Company Overview
      • 7.3.27.2. Financial Performance
      • 7.3.27.3. Product Benchmarking
      • 7.3.27.4. Strategic Initiatives
    • 7.3.28. Compex
      • 7.3.28.1. Company Overview
      • 7.3.28.2. Financial Performance
      • 7.3.28.3. Product Benchmarking
      • 7.3.28.4. Strategic Initiatives
    • 7.3.29. Pain Care Labs
      • 7.3.29.1. Company Overview
      • 7.3.29.2. Financial Performance
      • 7.3.29.3. Product Benchmarking
      • 7.3.29.4. Strategic Initiatives
    • 7.3.30. PowerCure Europe
      • 7.3.30.1. Company Overview
      • 7.3.30.2. Financial Performance
      • 7.3.30.3. Product Benchmarking
      • 7.3.30.4. Strategic Initiatives
  • 7.4. Company Profiles, R&D Focus and Sales Channel Analysis
    • 7.4.1. PAJUNK
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. OMRON Healthcare, Inc.
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Zynex Medical
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Litemed
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. DJO Global
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Boston Scientific Corporation
      • 7.4.6.1. Company Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. SPR
      • 7.4.7.1. Company Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Medtronic
      • 7.4.8.1. Company Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Nalu Medical, Inc.
      • 7.4.9.1. Company Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Abbott
      • 7.4.10.1. Company Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Atricure, Inc.
      • 7.4.11.1. Company Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives
    • 7.4.12. ThermaCare
      • 7.4.12.1. Company Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Strategic Initiatives
    • 7.4.13. Avanos Medical, Inc
      • 7.4.13.1. Company Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Strategic Initiatives
    • 7.4.14. ICU Medical, Inc.
      • 7.4.14.1. Company Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Strategic Initiatives
    • 7.4.15. Dynatronics Corporation
      • 7.4.15.1. Company Overview
      • 7.4.15.2. Financial Performance
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Strategic Initiatives
    • 7.4.16. RS Medical
      • 7.4.16.1. Company Overview
      • 7.4.16.2. Financial Performance
      • 7.4.16.3. Product Benchmarking
      • 7.4.16.4. Strategic Initiatives
    • 7.4.17. Bioventus
      • 7.4.17.1. Company Overview
      • 7.4.17.2. Financial Performance
      • 7.4.17.3. Product Benchmarking
      • 7.4.17.4. Strategic Initiatives
    • 7.4.18. BioElectronics Corporation
      • 7.4.18.1. Company Overview
      • 7.4.18.2. Financial Performance
      • 7.4.18.3. Product Benchmarking
      • 7.4.18.4. Strategic Initiatives
    • 7.4.19. ProMedTek Inc.
      • 7.4.19.1. Company Overview
      • 7.4.19.2. Financial Performance
      • 7.4.19.3. Product Benchmarking
      • 7.4.19.4. Strategic Initiatives
    • 7.4.20. InfuSystem
      • 7.4.20.1. Company Overview
      • 7.4.20.2. Financial Performance
      • 7.4.20.3. Product Benchmarking
      • 7.4.20.4. Strategic Initiatives
    • 7.4.21. Gladiator Therapeutics
      • 7.4.21.1. Company Overview
      • 7.4.21.2. Financial Performance
      • 7.4.21.3. Product Benchmarking
      • 7.4.21.4. Strategic Initiatives
    • 7.4.22. PAIN MANAGEMENT TECHNOLOGIES, INC.
      • 7.4.22.1. Company Overview
      • 7.4.22.2. Financial Performance
      • 7.4.22.3. Product Benchmarking
      • 7.4.22.4. Strategic Initiatives
    • 7.4.23. PainPod
      • 7.4.23.1. Company Overview
      • 7.4.23.2. Financial Performance
      • 7.4.23.3. Product Benchmarking
      • 7.4.23.4. Strategic Initiatives
    • 7.4.24. BioWave Corporation
      • 7.4.24.1. Company Overview
      • 7.4.24.2. Financial Performance
      • 7.4.24.3. Product Benchmarking
      • 7.4.24.4. Strategic Initiatives
    • 7.4.25. DIS&L
      • 7.4.25.1. Company Overview
      • 7.4.25.2. Financial Performance
      • 7.4.25.3. Product Benchmarking
      • 7.4.25.4. Strategic Initiatives
    • 7.4.26. TrueRelief, LLC
      • 7.4.26.1. Company Overview
      • 7.4.26.2. Financial Performance
      • 7.4.26.3. Product Benchmarking
      • 7.4.26.4. Strategic Initiatives
    • 7.4.27. MAI Medical
      • 7.4.27.1. Company Overview
      • 7.4.27.2. Financial Performance
      • 7.4.27.3. Product Benchmarking
      • 7.4.27.4. Strategic Initiatives
    • 7.4.28. Compex
      • 7.4.28.1. Company Overview
      • 7.4.28.2. Financial Performance
      • 7.4.28.3. Product Benchmarking
      • 7.4.28.4. Strategic Initiatives
    • 7.4.29. Pain Care Labs
      • 7.4.29.1. Company Overview
      • 7.4.29.2. Financial Performance
      • 7.4.29.3. Product Benchmarking
      • 7.4.29.4. Strategic Initiatives
    • 7.4.30. PowerCure Europe
      • 7.4.30.1. Company Overview
      • 7.4.30.2. Financial Performance
      • 7.4.30.3. Product Benchmarking
      • 7.4.30.4. Strategic Initiatives
  • 7.5. Company Profiles, EMS Providers In Pearl River Delta
    • 7.5.1. Shenzhen WELLD Medical Electronics Co., Ltd.
      • 7.5.1.1. Company Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Longest Medical
      • 7.5.2.1. Company Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Shenzhen Roundwhale Technology Co., Ltd
      • 7.5.3.1. Company Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Shenzhen Xinmaikang Technology Co., Ltd.
      • 7.5.4.1. Company Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Huizhou Huan Dong Industrial Co., Ltd.
      • 7.5.5.1. Company Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Yunblaze Technology China
      • 7.5.6.1. Company Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Hong Qiangxing (Shenzhen) Electronics Limited
      • 7.5.7.1. Company Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Shenzhen Jrw Technology Co., Ltd.
      • 7.5.8.1. Company Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Quanding Medical
      • 7.5.9.1. Company Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Shenzhen Xinkang Health Technology Co., Ltd.
      • 7.5.10.1. Company Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 North America Therapy Devices Market, Region, 2021 - 2033 (USD Million)
  • Table 4 North America Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 5 North America Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 6 U.S. Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 7 U.S. Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 Canada Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 9 Canada Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 10 Mexico Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 11 Mexico Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 12 Europe Therapy Devices Market, Region, 2021 - 2033 (USD Million)
  • Table 13 Europe Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 14 Europe Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 15 UK Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 16 UK Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Germany Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 18 Germany Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 19 France Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 20 France Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Italy Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 22 Italy Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 23 Spain Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 24 Spain Therapy Devices Market, By End Use 2021 - 2033 (USD Million)
  • Table 25 Sweden Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 26 Sweden Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 27 Norway Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 28 Norway Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 29 Denmark Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 30 Denmark Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 31 Asia Pacific Therapy Devices Market, Region, 2021 - 2033 (USD Million)
  • Table 32 Asia Pacific Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 33 Asia Pacific Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Japan Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 35 Japan Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 36 China Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 37 China Therapy Devices Market, By End Use 2021 - 2033 (USD Million)
  • Table 38 India Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 39 India Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 40 Australia Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 41 Australia Therapy Devices Market, By End Use 2021 - 2033 (USD Million)
  • Table 42 South Korea Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 43 South Korea Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 44 Thailand Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 45 Thailand Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Latin America Therapy Devices Market, Region, 2021 - 2033 (USD Million)
  • Table 47 Latin America Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 48 Latin America Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 49 Brazil Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 50 Brazil Therapy Devices Market, By End Use 2021 - 2033 (USD Million)
  • Table 51 Argentina Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 52 Argentina Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 53 MEA Therapy Devices Market, Region, 2021 - 2033 (USD Million)
  • Table 54 MEA Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 55 MEA Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 56 South Africa Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 57 South Africa Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Saudi Arabia Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 59 Saudi Arabia Therapy Devices Market, By End Use 2021 - 2033 (USD Million)
  • Table 60 UAE Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 61 UAE Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Kuwait Therapy Devices Market, By Application, 2021 - 2033 (USD Million)
  • Table 63 Kuwait Therapy Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 64 Key Pain Management Devices Companies Undergoing Product Launch
  • Table 65 Key Pain Management Devices Companies Undergoing Mergers and Acquisition
  • Table 66 Key Pain Management Devices Companies Undergoing Partnerships and Collaboration
  • Table 67 Key Pain Management Devices Companies Undergoing Expansion
  • Table 68 Key Pain Management Devices Companies Undergoing Other Strategies
  • Table 69 Key Rehabilitation & Physical Therapy Device Companies Undergoing Product Launch
  • Table 70 Key Rehabilitation & Physical Therapy Device Companies Undergoing Mergers and Acquisition
  • Table 71 Key Rehabilitation & Physical Therapy Device Companies Undergoing Partnerships and Collaboration
  • Table 72 Key Rehabilitation & Physical Therapy Device Companies Undergoing Expansion
  • Table 73 Key Rehabilitation & Physical Therapy Device Companies Undergoing Other Strategies
  • Table 74 Key Respiratory Therapy Device Companies Undergoing Product Launch
  • Table 75 Key Respiratory Therapy Device Companies Undergoing Mergers and Acquisitions
  • Table 76 Key Respiratory Therapy Device Companies Undergoing Partnerships and Collaboration
  • Table 77 Key Respiratory Therapy Device Companies Undergoing Expansion
  • Table 78 Key Respiratory Therapy Device Companies Undergoing Other Strategies
  • Table 79 Key Mental Health & Neurotherapy Companies Undergoing Product Launch
  • Table 80 Key Mental Health & Neurotherapy Companies Undergoing Mergers and Acquisitions
  • Table 81 Key Mental Health & Neurotherapy Ompanies Undergoing Partnerships and Collaboration
  • Table 82 Key Mental Health & Neurotherapy Companies Undergoing Expansion
  • Table 83 Key Mental Health & Neurotherapy Companies Undergoing Other Strategies
  • Table 84 Key Other Therapy Device Companies Undergoing Product Launch
  • Table 85 Key Other Therapy Device Companies Undergoing Mergers and Acquisitions
  • Table 86 Key Other Therapy Device Companies Undergoing Partnerships and Collaborations
  • Table 87 Key Other Therapy Device Companies Undergoing Expansion
  • Table 88 Key Other Therapy Device Companies Undergoing Other Strategies

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value-Chain-Based Sizing & Forecasting
  • Fig. 6 QFD Modeling For Market Share Assessment
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Therapy Devices Market: Market Outlook
  • Fig. 9 Therapy Devices Competitive Insights
  • Fig. 10 Parent Market Outlook
  • Fig. 11 Ancillary Market Outlook
  • Fig. 12 Global Therapy Devices Market Driver Impact
  • Fig. 13 Global Therapy Devices Market Restraint Impact
  • Fig. 14 Porter's Analysis
  • Fig. 15 PESTLE Analysis
  • Fig. 16 Therapy Devices Market: Application Movement Analysis
  • Fig. 17 Therapy Devices Market: Application Outlook and Key Takeaways
  • Fig. 18 Pain Management Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 19 Electrical stimulation (TENS/NMES) Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 20 Cryo / Thermotherapy Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 21 Laser Therapy Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 22 Ultrasound Therapy Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 23 Rehabilitation & Physical Therapy Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 24 Robotic Rehabilitation Systems Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 25 Virtual Reality Therapy Systems Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 26 Exoskeleton Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 27 Electromechanical Therapy Platforms Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 28 Mental Health & Neurotherapy Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 29 Neurostimulation (tDCS, TMS) Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 30 EEG-based Neurofeedback Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 31 Respiratory Therapy Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 32 CPAP / BiPAP Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 33 Non-invasive Ventilators/Resuscitators Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 34 Pulmonary Rehab Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 35 Nebulizers / Aerosol Systems Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 36 Others Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 37 Global Therapy Devices Market: Regional Movement Analysis
  • Fig. 38 Global Therapy Devices Market: Regional Outlook and Key Takeaways
  • Fig. 39 North America Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 40 Key Country Dynamics
  • Fig. 41 U.S. Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 42 Key Country Dynamics
  • Fig. 43 Canada Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 44 Key Country Dynamics
  • Fig. 45 Mexico Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 46 Europe Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 47 Key Country Dynamics
  • Fig. 48 UK Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 49 Key Country Dynamics
  • Fig. 50 Germany Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 51 Key Country Dynamics
  • Fig. 52 Spain Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 53 Key Country Dynamics
  • Fig. 54 France Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 55 Key Country Dynamics
  • Fig. 56 Italy Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 57 Key Country Dynamics
  • Fig. 58 Norway Therapy Devices Market Estimates and Forecast, 2021 - 2033 (USD million)
  • Fig. 59 Key Country Dynamics
  • Fig. 60 Denmark Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 61 Key Country Dynamics
  • Fig. 62 Sweden Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 63 Asia Pacific Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 64 Key Country Dynamics
  • Fig. 65 Japan Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 66 Key Country Dynamics
  • Fig. 67 China Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 68 Key Country Dynamics
  • Fig. 69 India Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 70 Key Country Dynamics
  • Fig. 71 Australia Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 72 Key Country Dynamics
  • Fig. 73 South Korea Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 74 Key Country Dynamics
  • Fig. 75 Thailand Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 76 Latin America Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 77 Key Country Dynamics
  • Fig. 78 Brazil Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 79 Key Country Dynamics
  • Fig. 80 Argentina Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 81 MEA Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 82 Key Country Dynamics
  • Fig. 83 South Africa Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 84 Key Country Dynamics
  • Fig. 85 Saudi Arabia Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 86 Key Country Dynamics
  • Fig. 87 UAE Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 88 Key Country Dynamics
  • Fig. 89 Kuwait Therapy Devices Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million)
  • Fig. 90 Key company categorization
  • Fig. 91 Heat map analysis 2025
  • Fig. 92 Strategy mapping of pain management devices
  • Fig. 93 Strategy mapping of rehabilitation & physical therapy devices
  • Fig. 94 Strategy mapping of respiratory therapy devices
  • Fig. 95 Strategy mapping of mental health & neurotherapy devices
  • Fig. 96 Strategy mapping of other devices